Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues

…, CP Peters, M Munneke, AA Te Velde, SL Meijer… - Nature …, 2013 - nature.com
Innate lymphoid cells (ILCs) are effectors of innate immunity and regulators of tissue modeling.
Recently identified ILC populations have a cytokine expression pattern that resembles …

Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial

…, M Visser, GJ Offerhaus, CA Seldenrijk, SL Meijer… - Jama, 2014 - jamanetwork.com
Importance Barrett esophagus containing low-grade dysplasia is associated with an
increased risk of developing esophageal adenocarcinoma, a cancer with a rapidly increasing …

Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel

…, KN Phoa, WL Curvers, FJW Ten Kate, GA Meijer… - Gut, 2015 - gut.bmj.com
Objective Reported malignant progression rates for low-grade dysplasia (LGD) in Barrett's
oesophagus (BO) vary widely. Expert histological review of LGD is advised, but limited data …

Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study

…, FJW Ten Kate, M Visser, SL Meijer… - Gastroenterology, 2013 - Elsevier
BACKGROUND & AIMS: Radiofrequency ablation (RFA), with or without endoscopic
resection effectively eradicates Barrett’s esophagus (BE) containing high-grade intraepithelial …

Neoadjuvant chemoradiotherapy combined with atezolizumab for resectable esophageal adenocarcinoma: a single-arm phase II feasibility trial (PERFECT)

…, ED Geijsen, RHA Verhoeven, SL Meijer… - Clinical Cancer …, 2021 - AACR
Purpose: The CROSS trial established neoadjuvant chemoradiotherapy (nCRT) for patients
with resectable esophageal adenocarcinoma (rEAC). In the PERFECT trial, we investigated …

Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study

…, HWM van Laarhoven, SL Meijer, L Goense… - The Lancet …, 2018 - thelancet.com
Background After neoadjuvant chemoradiotherapy for oesophageal cancer, roughly half of
the patients with squamous cell carcinoma and a quarter of those with adenocarcinoma have …

Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma

…, C Waasdorp, GKJ Hooijer, SL Meijer… - Proceedings of the …, 2019 - National Acad Sciences
Esophageal adenocarcinoma (EAC) has a dismal prognosis, and survival benefits of recent
multimodality treatments remain small. Cancer-associated fibroblasts (CAFs) are known to …

Computer-aided detection of early Barrett's neoplasia using volumetric laser endomicroscopy

…, SR Klomp, S Zinger, SL Meijer… - Gastrointestinal …, 2017 - Elsevier
Background and Aims Volumetric laser endomicroscopy (VLE) is an advanced imaging
system that provides a near-microscopic resolution scan of the esophageal wall layers up to 3-…

[HTML][HTML] Deep learning for automatic Gleason pattern classification for grade group determination of prostate biopsies

M Lucas, I Jansen, CD Savci-Heijink, SL Meijer… - Virchows Archiv, 2019 - Springer
Histopathologic grading of prostate cancer using Gleason patterns (GPs) is subject to a
large inter-observer variability, which may result in suboptimal treatment of patients. With the …

Discordance among pathologists in the United States and Europe in diagnosis of low-grade dysplasia for patients with Barrett's esophagus

…, SC Mathur, DT Patil, GJ Offerhaus, SL Meijer… - Gastroenterology, 2017 - Elsevier
Background & Aims There is suboptimal inter-observer agreement, even among expert
gastrointestinal pathologists, in the diagnosis of low-grade dysplasia (LGD) in patients with …